US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

58.33

+0.25000.43%

Pre-market: 59.310.9800+1.68%07:28 EDT

Volume:13.42M

Turnover:778.95M

Market Cap:258.93B

PE:18.57

High:59.30

Open:58.25

Low:57.00

Close:58.08

Loading ...

Overview Company News Filings

Novo Nordisk Had Constructive Quarter, But U.S. Volumes a Concern -- Market Talk

UBS Remains a Buy on Novo Nordisk (0QIU)

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025

Novo Nordisk Q1 Earnings Likely to Miss Estimates on Slower Ozempic, Wegovy Sales, BofA Says

MT Newswires Live

Novo Nordisk First Quarter Earnings Could Disappoint, BofA Says -- Market Talk

Lexicon Pharmaceuticals Shares Soar on Novo Nordisk Licensing Deal

BofA cuts Novo Nordisk shares target on expected Q1 earnings miss

Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851

Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market

J.P. Morgan Keeps Their Buy Rating on Novo Nordisk (0QIU)

Why Novo Nordisk Stock Dipped on Thursday

Wegovy sales took a hit this year. Novo's CEO blames off-brand competition

Novo Nordisk price target lowered to DKK 600 from DKK 700 at Morgan Stanley

Novo Nordisk Stock (NVO) Sees Its Largest Monthly Drop Since 2002

Novo Nordisk A/S Stock Falls Thursday, Underperforms Market

Novo Nordisk's Wegovy Sales Growth Stalls in U.S. Amid Competition, Reimbursement Hurdles -- Market Talk

Market Chatter: Novo Nordisk Settles Federal Lawsuit Over Insulin Prices in Minnesota

MT Newswires Live

GLP-1s are driving returns on R&D investments for Big Pharma, report says

This Company Just Overtook Ozempic Maker Novo Nordisk as Europe's Most Valuable -- Barrons.com

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NVO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO\",,,,,undefined,":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"Novo-Nordisk A/S","latestPrice":58.33,"timestamp":1745265600000,"preClose":58.08,"halted":0,"volume":13419321,"hourTrading":{"tag":"盘前","latestPrice":59.31,"preClose":58.33,"latestTime":"07:28 EDT","volume":313031,"amount":18792044.776616,"timestamp":1745321325831},"delay":0,"floatShares":3183551536,"shares":4439052849,"eps":3.141546,"marketStatus":"Pre-Mkt","change":0.25,"latestTime":"04-22 07:29:13 EDT","open":58.25,"high":59.3,"low":57,"amount":778952305.697433,"amplitude":0.039601,"askPrice":59.41,"askSize":400,"bidPrice":59.33,"bidSize":1310,"shortable":3,"etf":0,"ttmEps":3.141546,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":58.33,"dividendRate":0.028764,"preHourTrading":{"tag":"盘前","latestPrice":59.31,"preClose":58.33,"latestTime":"07:28 EDT","volume":313031,"amount":18792044.776616,"timestamp":1745321325831},"postHourTrading":{"tag":"盘后","latestPrice":58.7268,"preClose":58.33,"latestTime":"19:59 EDT","volume":76176,"amount":4456781.8966,"timestamp":1745279986865},"volumeRatio":1.0455248120619738,"optionData":{"bulkOrders":[{"symbol":"NVO","call":false,"expireDate":1768539600000,"strike":"45.0","timestamp":1745257165824,"price":3.65,"volume":2000,"amount":730000,"type":"-"}]},"impliedVol":0.6184,"impliedVolPercentile":0.9438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO\",,,,,undefined,":{"symbol":"NVO","floatShares":3183551536,"roa":"22.41%","roe":"80.78%","lyrEps":3.147662,"volumeRatio":1.0455248120619738,"shares":4439052849,"dividePrice":1.677784,"high":59.3,"amplitude":0.039601,"preClose":58.08,"low":57,"week52Low":57,"pbRate":"12.26","psRate":"6.06","week52High":148.15,"institutionHeld":0.2044,"latestPrice":58.33,"committee":0.532164,"eps":3.141546,"divideRate":0.028764,"volume":13419321,"delay":0,"ttmEps":3.141546,"open":58.25,"prevYearClose":86.02,"prevWeekClose":58.08,"prevMonthClose":69.44,"prevQuarterClose":69.44,"fiveDayClose":64.73,"twentyDayClose":76.86,"sixtyDayClose":81.1,"earningDate":1746547200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523294130","title":"Novo Nordisk Had Constructive Quarter, But U.S. Volumes a Concern -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2523294130","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523294130?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:49","pubTimestamp":1743425340,"startTime":"0","endTime":"0","summary":"1249 GMT - Novo Nordisk has had a constructive first quarter on many fronts, but Barclays lowers its forecasts heading into the earnings report on lower Wegovy and Ozempic volumes in the U.S. than it previously forecast. Novo Nordisk has come off the FDA drugs shortage list and introduced its NovoCare direct-to-patient pharmacy efforts. But prescriptions didn't grow to the extent the bank needed them to in order to meet its forecasts. The bank now expects group sales growth this year at 19% at constant exchange rates, below the midpoint of company guidance at 16%-24%. A guidance cut at the first-quarter earnings report is \"certainly possible, although Barclays continues to believe in the long-term story. Shares fall 2.3%. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2523064693","title":"UBS Remains a Buy on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523064693","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523064693?lang=en_us&edition=fundamental","pubTime":"2025-03-30 08:05","pubTimestamp":1743293104,"startTime":"0","endTime":"0","summary":"UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) on March 28 and set a price target of DKK750.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-buy-on-novo-nordisk-0qiu-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-buy-on-novo-nordisk-0qiu-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4585","LU1093756168.USD","LU1093756325.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4007","NVO","LU0154236417.USD","BK4599","BK4588"],"gpt_icon":0},{"id":"2523619084","title":"Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523619084","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523619084?lang=en_us&edition=fundamental","pubTime":"2025-03-30 02:33","pubTimestamp":1743273180,"startTime":"0","endTime":"0","summary":"Rybelsus reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial1.Data were presented at the American College of Cardiology's  Annual Scientific Session and Expo in Chicago, US, while simultaneously published today in New England Journal of Medicine2.Rybelsus, the only approved oral GLP-1 medicine, demonstrated this risk reduction on top of standards of cardiovascular and diabetes care.Based on SOUL findings, Novo Nordisk submitted a label extension application for Rybelsus for CV event risk reduction to the US FDA and EMA.Bagsvrd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus  significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease  and/or chronic kidney disease 1. These new data from the pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-rybelsus-oral-semaglutide-183300199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","LU0154236417.USD","BK4532","MACE","BK4588","BK4183","LU1093756325.SGD","IE00BKVL7J92.USD","BK4007","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4157","NVO","BK4585"],"gpt_icon":1},{"id":"2523690296","title":"Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523690296","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523690296?lang=en_us&edition=fundamental","pubTime":"2025-03-29 22:33","pubTimestamp":1743258780,"startTime":"0","endTime":"0","summary":"Ozempic improved maximum walking distance by 13% vs placebo in adults with type 2 diabetes and peripheral artery disease  in the phase 3 STRIDE trial1.Data were presented at the American College of Cardiology's  Annual Scientific Session and Expo in Chicago, US, while simultaneously published today in The Lancet2.Approximately 230 million people globally have PAD, a severe form of atherosclerotic cardiovascular disease3, and nearly one in three people with PAD have type 2 diabetes4.Bagsvrd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease  outcomes trial investigating the effects of once-weekly injectable Ozempic  in adults with type 2 diabetes and PAD, at the American College of Cardiology's  Annual Scientific Session and Expo in Chicago, US1. These new data from the phase 3 trial were featured during a late-breaking clinical trial session at the ACC and simultaneously published today in The Lancet2.PAD is a sever","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ozempic-once-weekly-semaglutide-1-143300469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4599","NVO","LU1093756168.USD","BK4588","LU1093756325.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4007","BK4532","LU0154236417.USD"],"gpt_icon":1},{"id":"2523450717","title":"Novo Nordisk Q1 Earnings Likely to Miss Estimates on Slower Ozempic, Wegovy Sales, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2523450717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523450717?lang=en_us&edition=fundamental","pubTime":"2025-03-29 00:07","pubTimestamp":1743178079,"startTime":"0","endTime":"0","summary":"Novo Nordisk's (NVO) Q1 2025 earnings are likely to miss consensus estimates due to slower-than-expected sales growth of its key drugs, Ozempic and Wegovy, and unfavorable foreign exchange rates, BofA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO"],"gpt_icon":1},{"id":"2522501127","title":"Novo Nordisk First Quarter Earnings Could Disappoint, BofA Says -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2522501127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522501127?lang=en_us&edition=fundamental","pubTime":"2025-03-28 23:11","pubTimestamp":1743174660,"startTime":"0","endTime":"0","summary":"1511 GMT - Novo Nordisk first-quarter earnings could miss expectations on lower-than-expected prescriptions of Ozempic and Wegovy as well as some price declines, Bank of America Securities analysts write. Growth will also be hit by tough comparables, currency impacts and possibly higher costs, the bank says. \"We expect sales guide to be lowered from 16-24% at constant exchange rates to 14%-22%, with our forecasts at the bottom of the new range.\" BofA assumes limited Ozempic/Wegovy inflection in the second quarter, while a key unknown is if whether a second-half inflection in prescriptions happens against tougher comparables. The bank lowers its price objective to 910 Danish kroner from 1,075 kroner and keeps a buy rating. Shares trade at 475.00 kroner. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2522503339","title":"Lexicon Pharmaceuticals Shares Soar on Novo Nordisk Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2522503339","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522503339?lang=en_us&edition=fundamental","pubTime":"2025-03-28 22:09","pubTimestamp":1743170940,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals shares jumped nearly 75% in early trading Friday after the biopharmaceutical company inked a license agreement potentially worth $1 billion with Danish drug maker Novo Nordisk.Shares of Lexicon, based in The Woodlands, Texas, were recently changing hands at 60.4 cents, up 74%.Lexicon said the agreement gives Novo Nordisk an exclusive, worldwide license to develop, manufacture and commercialize LX9851, which is in development for the treatment of obesity and associated cardiometabolic disorders.Lexicon said it will receive an upfront payment of $45 million from Novo Nordisk, which makes the blockbuster weight-loss drugs Ozempic and Wegovy.Lexicon is also eligible for up to $960 million in development, regulatory and sales milestone payments, along with royalties on sales of LX9851.Lexicon last year said preclinical data show that LX9851 significantly reduced weight, food intake and fat mass in mice when combined with semaglutide, the key ingredient in Ozempic and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX","NVO"],"gpt_icon":1},{"id":"2522055235","title":"BofA cuts Novo Nordisk shares target on expected Q1 earnings miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2522055235","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522055235?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:54","pubTimestamp":1743170061,"startTime":"0","endTime":"0","summary":"Investing.com -- Bank of America  on Friday lowered its price target for  Novo Nordisk  k  shares, cautioning that the company may miss its first-quarter earnings projections as sales of its megahit drugs Wegovy and Ozempic, lag.BofA analysts expect Novo Nordisk's first-quarter sales to reach 77 billion Danish kroner , a 17% year-over-year increase, and earnings before interest and taxes  to hit DKK 36 billion, up 14% from the previous year. These figures are approximately 1-2% below the Visible Alpha consensus.The analysts have identified several key factors that could contribute to a potential earnings miss for the first quarter.These include a challenging comparison with the first quarter of 2024 due to a large gross-to-net  benefit that significantly boosted growth, as well as the highest margin quarter of fiscal year 2024, which sets a high comparison baseline.Looking ahead, BofA expects Novo Nordisk to lower its sales guidance from 16-24% in constant exchange rates  to 14-22%, wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bofa-cuts-novo-nordisk-shares-135421763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVO"],"gpt_icon":1},{"id":"2522224573","title":"Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851","url":"https://stock-news.laohu8.com/highlight/detail?id=2522224573","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522224573?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:30","pubTimestamp":1743161400,"startTime":"0","endTime":"0","summary":"Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and near-term milestone payments. THE WOODLANDS, Texas, March 28, 2025  -- Lexicon Pharmaceuticals, Inc.  today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for LX9851, a first-in-class, oral non-incretin development candidate in obesity and associated metabolic disorders. Under the terms of the agreement, Novo Nordisk obtains an exclusive, worldwide license to develop, manufacture and commercialize LX9851 in all indications. Lexicon will be responsible for completing agreed upon Investigational New Drug  application-enabling activities for LX9851. Novo Nordisk will be responsible for filing the IND, all further development, manufacturing and commercialization of LX9851.Lexicon is eligible to receive upfront and near-term milestone payments of up to $75 million. In total, Lexicon will be eligible to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4a641e4e4a3f19d0d6240caa73da3835","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexicon-pharmaceuticals-announces-exclusive-license-113000573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","LXRX","BK4139","LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4599","BK4007","BK4532","IE00BKVL7J92.USD","BK4588"],"gpt_icon":1},{"id":"2522695522","title":"Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522695522","media":"Moneywise","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522695522?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:19","pubTimestamp":1743157140,"startTime":"0","endTime":"0","summary":"Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed a $2 billion deal to acquire the global rights to an experimental obesity treatment from China’s United Bio-Technology  Co.The March 24 agreement includes milestone payments of up to $1.8 billion, plus tiered royalties.I'm 49 years old and have nothing saved for retirement — what should I do?Don't panic. Here are 5 of the easiest ways you can catch up . Find out how you can access this $1B private real estate fund . Americans with upside-down car loans owe more money than ever before — and drivers can’t keep up. Here are 3 ways to cut your monthly costs ASAP. The new drug in question, UBT251, is a next-generation therapy designed to tackle obesity and type 2 diabetes by targeting three key hormones including, GLP-1 and GIP — which regulate appetite and blood sugar — and glucagon, which helps stabilize blood sugar levels.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-2b-deal-obesity-101900295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","BK4007","NVO","IE00BKVL7J92.USD","BK4585","LU1093756325.SGD","BK4599","LU0154236417.USD"],"gpt_icon":1},{"id":"2522544809","title":"J.P. Morgan Keeps Their Buy Rating on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522544809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522544809?lang=en_us&edition=fundamental","pubTime":"2025-03-28 16:55","pubTimestamp":1743152119,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK1,000.00. Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-buy-rating-on-novo-nordisk-0qiu-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-buy-rating-on-novo-nordisk-0qiu-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVO"],"gpt_icon":0},{"id":"2522555455","title":"Why Novo Nordisk Stock Dipped on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2522555455","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522555455?lang=en_us&edition=fundamental","pubTime":"2025-03-28 06:36","pubTimestamp":1743114960,"startTime":"0","endTime":"0","summary":"The high-profile Danish pharmaceutical company got a price-target cut from an analyst.That pundit remains lukewarm at best on the Wegovy maker's prospects.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/27/why-novo-nordisk-stock-dipped-on-thursday/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1668664300.SGD","IE00BKVL7J92.USD","LU1989772840.SGD","LU1074936037.SGD","LU0320765646.SGD","LU0971096721.USD","LU0154236417.USD","LU2347655156.SGD","LU0314104364.USD","LU1989772923.USD","BK4599","LU0795875086.SGD","LU1720051108.HKD","BK4534","LU0106831901.USD","LU2133065610.SGD","LU0098860793.USD","LU2111349929.HKD","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4127","LU0158827781.USD","BK4532","BK4007","BK4504","LU0912757837.SGD","LU2089283258.USD","LU0795875169.SGD","LU0158827948.USD","LU1363072403.SGD","LU1162221912.USD","BK4588","LU0267386448.USD","LU2023251221.USD","NVO","LU1548497426.USD","BK4585","BK4581","LU2089284900.SGD","LU0225283273.USD","LU1093756168.USD","LU2028103732.USD","LU2271345857.HKD","LU1720051017.SGD","BK4516","LU0006306889.USD","LU1732799900.SGD","LU2357305700.SGD","LU1732800096.USD","LU0106261372.USD"],"gpt_icon":1},{"id":"2522089530","title":"Wegovy sales took a hit this year. Novo's CEO blames off-brand competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2522089530","media":"Quartz","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522089530?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:04","pubTimestamp":1743109440,"startTime":"0","endTime":"0","summary":"In this photo illustration, the injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. - Image: Scott Olson / Staff . Compounding refers to the custom preparation of an otherwise branded drug by a pharmacy or physician to meet the specific needs of an individual patient. Drugs can also be compounded under other conditions, including when a patented medication is in short supply. But with Novo Nordisk ramping up production and Wegovy no longer on the Food and Drug Administration’s  shortage list, the pharma giant claims that most compounded versions are no longer justified. The FDA has also said it could start citing companies and healthcare providers that continue to offer certain versions of compounded semaglutide starting as early as May 22. Novo Nordisk lists Wegovy at $1,349.02 per month, anddrug-shortage rules allowed compounders to sell versions of the drug at lower prices.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wegovy-sales-took-hit-novos-210400146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVO"],"gpt_icon":1},{"id":"2522357035","title":"Novo Nordisk price target lowered to DKK 600 from DKK 700 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2522357035","media":"TIPRANKS","labels":["rating"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522357035?lang=en_us&edition=fundamental","pubTime":"2025-03-28 03:15","pubTimestamp":1743102955,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Thibault Boutherin lowered the firm’s price target on Novo Nordisk (NVO) to DKK 600 from DKK 700 and keeps an Equal Weight r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-600-from-dkk-700-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-600-from-dkk-700-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVO"],"gpt_icon":0},{"id":"2522535083","title":"Novo Nordisk Stock (NVO) Sees Its Largest Monthly Drop Since 2002","url":"https://stock-news.laohu8.com/highlight/detail?id=2522535083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522535083?lang=en_us&edition=fundamental","pubTime":"2025-03-28 03:12","pubTimestamp":1743102747,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest monthly loss since July 200...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-sees-its-largest-monthly-drop-since-2002?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-sees-its-largest-monthly-drop-since-2002?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","LU0154236417.USD","NVO","BK4532","BK4585","BK4007"],"gpt_icon":0},{"id":"2522584260","title":"Novo Nordisk A/S Stock Falls Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522584260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522584260?lang=en_us&edition=fundamental","pubTime":"2025-03-28 01:03","pubTimestamp":1743094980,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slid 3.8% to DKK480.60 Thursday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 1.6% to 2,442.44.This was the stock's seventh consecutive day of losses.The company closed DKK552.60 below its 52-week high of DKK1,033.20, which the company achieved on June 26, 2024.Trading volume was 6,639,318, compared to the 50-day average trading volume of 4,810,194.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2522340301","title":"Novo Nordisk's Wegovy Sales Growth Stalls in U.S. Amid Competition, Reimbursement Hurdles -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2522340301","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522340301?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:45","pubTimestamp":1743083100,"startTime":"0","endTime":"0","summary":"1344 GMT - Novo Nordisk sees flat U.S. weekly prescription rate growth for its obesity treatment Wegovy due to competition from U.S. rival Eli Lilly and compounding pharmacies, coupled with reimbursement challenges, Morgan Stanley analysts say. The Danish pharmaceutical company could trim its sales guidance, possibly alongside its 1Q results, due to the slower U.S. prescription growth, they say. While long-term forecasts still indicate potential upside, the future of the obesity market, peak sales potential and longevity of Novo Nordisk's weight loss drug portfolio remain uncertain, they add. The analysts also cite Eli Lilly's market share gains in the U.S. and product differentiation, including greater weight loss and better tolerability. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"gpt_icon":1},{"id":"2522399173","title":"Market Chatter: Novo Nordisk Settles Federal Lawsuit Over Insulin Prices in Minnesota","url":"https://stock-news.laohu8.com/highlight/detail?id=2522399173","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522399173?lang=en_us&edition=fundamental","pubTime":"2025-03-27 02:17","pubTimestamp":1743013052,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) settlement on the out-of-pocket price cap of insulin for Minnesota residents at $35 per month for the next five years was approved by a federal court in New Jersey, Bloomberg report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","LU0154236417.USD","NVO","NVO.AU","IE00BKVL7J92.USD","US5Y.BOND","US2Y.BOND","US10Y.BOND","LU1093756168.USD","US3Y.BOND","US30Y.BOND","BK4585","US7Y.BOND","BK4532","US6M.BOND","US12M.BOND","BK4007","BK4599","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588"],"gpt_icon":1},{"id":"2522988420","title":"GLP-1s are driving returns on R&D investments for Big Pharma, report says","url":"https://stock-news.laohu8.com/highlight/detail?id=2522988420","media":"Quartz","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522988420?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:26","pubTimestamp":1742927160,"startTime":"0","endTime":"0","summary":"In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. - Image: Mario Tama / Staff . Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s  popular diabetes drug Ozempic.Deloitte’s annual report, Measuring the Return from Pharmaceutical Innovation, found that GLP-1 drugs could fuel significant returns on research and development investments made last year by major drugmakers. The consulting firm analyzed the projected internal rate of return for late-stage pipeline assets across the 20 leading pharma companies.GLP-1 drugs mimic hormones that regulate blood sugar and suppress appetite, making them highly sought after for treating obesity and Type 2 diabetes. The surging demand has propelled Eli Lilly  and Novo Nordisk into becoming the largest pharma companies in the world. Eli Lilly’s weight-loss drug Zepbound generated $4.9 billion in annual revenu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/glp-1s-driving-returns-r-182600084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1712237335.SGD","LU0689472784.USD","LU1623119135.USD","LU0823416689.USD","LU0154236417.USD","IE0004445239.USD","LU2357305700.SGD","LU2237443465.HKD","LU2468319806.SGD","BK4581","LU2461242641.AUD","SGXZ99366536.SGD","LU0094547139.USD","LU1093756325.SGD","LU1267930730.SGD","LU1974910355.USD","LU0256863902.USD","NVO","SG9999018857.SGD","LU0820561909.HKD","LU0096364046.USD","LLY","SG9999018865.SGD","LU2237443549.SGD","LU2063271972.USD","GLP","LU0385154629.USD","BK4516","LU2602419157.SGD","LU1291159041.SGD","LU0417517546.SGD","LU1551013425.SGD","BK4590","LU2265009873.SGD","LU0097036916.USD","SG9999015978.USD","LU0109391861.USD","LU2324357040.USD","SG9999015986.USD","LU1720051108.HKD","LU1868837136.USD","IE00BK4W5M84.HKD","LU1061106388.HKD","LU1989771016.USD","LU0203202063.USD","LU1366192091.USD","LU2023250504.SGD","SG9999015952.SGD","SG9999014914.USD","LU2264538146.SGD"],"gpt_icon":1},{"id":"2522503026","title":"This Company Just Overtook Ozempic Maker Novo Nordisk as Europe's Most Valuable -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2522503026","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522503026?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:25","pubTimestamp":1742901900,"startTime":"0","endTime":"0","summary":"Novo Nordisk is no longer the king of publicly-listed European companies.The Ozempic maker's Copnehagen-listed stock slipped 1.3%, Monday to take its total market capitalization to  just under 2.33 trillion Danish kroner , according to Dow Jones Market Data.That meant that SAP took its crown. The German software company's Frankfurt-listed shares rose 1.3% Monday to lift its total market cap to 313.70 billion euros .The two stocks have been moving in different directions for months -- and that says something about the broader market. Novo has plummeted 41% over the past year as the weight-loss drugs boom has fizzled out, while SAP has risen by the same amount.It's benefited from the artificial-intelligence investing craze, which is expected to boost revenue for its cloud-computing division, as well as a broader rotation from U.S. to European stocks amid worries that President Donald Trump's tariffs will fuel a flare-up in inflation and drag down growth.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","MKR.USD.CC","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4528","SAP","LU0154236417.USD","LU1093756168.USD","MKR.USD.HKCC","LU1093756325.SGD","BK4585","BK4007","BK4588","BK4532","BK4613","BK4023","NVO"],"gpt_icon":1}],"pageSize":20,"totalPage":20,"pageCount":5,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVO\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"NVO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.91,"defaultRemindTime":1746604800000,"name":null,"time":"Pre-Market","dateTimestamp":1746590400000,"actualEps":null},{"date":"2025-03-31","symbol":"NVO","amount":1.09921,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"诺和诺德","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-08","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-08"},{"market":"US","date":"2025-02-05","symbol":"NVO","fiscalQuarterEnding":"2024/12","expectedEps":0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738731600000,"reportTimeType":"pre","actualEps":0.91},{"market":"US","date":"2024-11-06","symbol":"NVO","fiscalQuarterEnding":"2024/09","expectedEps":0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":0.9},{"date":"2024-08-16","symbol":"NVO","amount":0.5126402,"announcedDate":"2024-08-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-16","defaultRemindTime":1723815000000,"name":"诺和诺德","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-26","payableDate":"2024-08-16","currency":"USD","dateTimestamp":1723780800000,"payDate":"2024-08-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVO\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-30","value":0.699443,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-08-23","value":0.331026,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-04-04","value":0.479369,"currency":"USD"},{"executeDate":"2017-08-17","recordDate":"2017-08-21","paymentDate":"2017-08-29","value":0.335753,"currency":"USD"},{"executeDate":"2017-08-18","recordDate":"2017-08-21","paymentDate":"2017-08-29","value":0.335753,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.4,"hold":0.3333,"sell":0,"strongSell":0.0667,"meanLabel":"BUY","meanPercent":0.4,"analysts":15,"updateTime":1745121600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVO","date":"2025-04-17","current":18.516566,"percent":0.002433,"low":17.756123,"twenty":25.17357,"median":35.432631,"eighty":42.141973,"high":49.958416,"avg":34.665015,"sd":7.807516,"marketCap":284856366575.72},"quantilePoints":[{"date":"2020-04-24","current":26.867421,"twenty":18.894428,"median":20.079477,"eighty":21.907483,"marketCap":151545104532.4},{"date":"2020-05-01","current":25.955394,"twenty":18.895849,"median":20.087864,"eighty":21.978532,"marketCap":149255788342.56},{"date":"2020-05-08","current":25.051001,"twenty":18.906558,"median":20.094237,"eighty":22.005976,"marketCap":147275632655.31},{"date":"2020-05-15","current":25.409708,"twenty":18.912406,"median":20.101278,"eighty":22.0296,"marketCap":148873463092.12},{"date":"2020-05-22","current":25.872228,"twenty":18.912629,"median":20.123954,"eighty":22.063654,"marketCap":152694221841.1},{"date":"2020-05-29","current":25.214058,"twenty":18.914534,"median":20.149096,"eighty":22.16643,"marketCap":152054422411.2},{"date":"2020-06-05","current":24.81723,"twenty":18.918665,"median":20.160906,"eighty":22.207177,"marketCap":152106950250.68},{"date":"2020-06-12","current":24.967462,"twenty":18.920381,"median":20.181556,"eighty":22.293977,"marketCap":152137118068.5},{"date":"2020-06-19","current":25.953133,"twenty":18.921665,"median":20.208932,"eighty":22.344279,"marketCap":157406588494.26},{"date":"2020-06-26","current":25.41017,"twenty":18.927007,"median":20.222925,"eighty":22.368966,"marketCap":154425521338.95},{"date":"2020-07-02","current":25.387131,"twenty":18.930302,"median":20.237258,"eighty":22.454741,"marketCap":154716035044.13},{"date":"2020-07-10","current":24.928281,"twenty":18.932061,"median":20.244736,"eighty":22.618377,"marketCap":152965572667.12},{"date":"2020-07-17","current":25.127545,"twenty":18.934284,"median":20.248617,"eighty":22.717096,"marketCap":155883422581.28},{"date":"2020-07-24","current":24.48432,"twenty":18.935585,"median":20.254723,"eighty":22.918823,"marketCap":154675327844.66},{"date":"2020-07-31","current":24.047966,"twenty":18.940507,"median":20.277143,"eighty":23.068391,"marketCap":154231394914.19},{"date":"2020-08-07","current":22.873108,"twenty":18.962048,"median":20.286764,"eighty":23.098802,"marketCap":150039892807.22},{"date":"2020-08-14","current":23.351095,"twenty":18.97422,"median":20.297567,"eighty":23.129564,"marketCap":153696547258.82},{"date":"2020-08-21","current":23.506307,"twenty":18.97422,"median":20.338835,"eighty":23.173103,"marketCap":154147099905.35},{"date":"2020-08-28","current":23.233813,"twenty":18.976693,"median":20.346449,"eighty":23.199328,"marketCap":153902794177.21},{"date":"2020-09-04","current":22.975477,"twenty":18.979696,"median":20.359122,"eighty":23.203533,"marketCap":150923104804.78},{"date":"2020-09-11","current":23.492497,"twenty":18.980624,"median":20.379539,"eighty":23.221624,"marketCap":154858249083.45},{"date":"2020-09-18","current":24.430548,"twenty":18.980813,"median":20.408133,"eighty":23.259229,"marketCap":161415364546.47},{"date":"2020-09-25","current":24.671829,"twenty":18.987374,"median":20.422343,"eighty":23.293451,"marketCap":159465969885.43},{"date":"2020-10-02","current":24.503203,"twenty":18.99947,"median":20.465963,"eighty":23.341957,"marketCap":159867917489.8},{"date":"2020-10-09","current":25.468325,"twenty":19.006376,"median":20.476897,"eighty":23.376076,"marketCap":167575953324.27},{"date":"2020-10-16","current":25.367025,"twenty":19.012629,"median":20.495458,"eighty":23.433966,"marketCap":165474367315.48},{"date":"2020-10-23","current":24.977035,"twenty":19.016381,"median":20.509253,"eighty":23.478521,"marketCap":164690165254.72},{"date":"2020-10-30","current":22.964768,"twenty":19.01811,"median":20.523682,"eighty":23.497462,"marketCap":149317905417.56},{"date":"2020-11-06","current":24.836576,"twenty":19.01811,"median":20.557138,"eighty":23.512582,"marketCap":164585520531.77},{"date":"2020-11-13","current":23.92135,"twenty":19.018151,"median":20.586004,"eighty":23.556384,"marketCap":157749938193.53},{"date":"2020-11-20","current":23.798479,"twenty":19.018905,"median":20.596668,"eighty":23.559097,"marketCap":157395701186.22},{"date":"2020-11-27","current":23.366057,"twenty":19.020013,"median":20.62528,"eighty":23.557037,"marketCap":155953935937.08},{"date":"2020-12-04","current":23.128769,"twenty":19.02074,"median":20.635044,"eighty":23.548046,"marketCap":156651229493.06},{"date":"2020-12-11","current":23.741089,"twenty":19.024249,"median":20.65426,"eighty":23.559566,"marketCap":160498031078.69},{"date":"2020-12-18","current":24.859864,"twenty":19.032057,"median":20.684505,"eighty":23.60196,"marketCap":169745752365.84},{"date":"2020-12-24","current":23.71641,"twenty":19.035885,"median":20.691944,"eighty":23.647275,"marketCap":161362260340.54},{"date":"2020-12-31","current":23.752597,"twenty":19.043669,"median":20.700113,"eighty":23.655219,"marketCap":162141509961.91},{"date":"2021-01-08","current":23.696925,"twenty":19.054553,"median":20.702874,"eighty":23.669838,"marketCap":162085386745.31},{"date":"2021-01-15","current":24.63696,"twenty":19.057389,"median":20.716876,"eighty":23.708595,"marketCap":166433622652.22},{"date":"2021-01-22","current":24.733507,"twenty":19.062993,"median":20.723709,"eighty":23.71641,"marketCap":168128182581.6},{"date":"2021-01-29","current":23.66534,"twenty":19.066991,"median":20.74808,"eighty":23.736593,"marketCap":160442919521.41},{"date":"2021-02-05","current":24.144958,"twenty":19.074243,"median":20.76778,"eighty":23.752597,"marketCap":164540849620.52},{"date":"2021-02-12","current":25.225531,"twenty":19.07899,"median":20.797565,"eighty":23.777504,"marketCap":173229483939.31},{"date":"2021-02-19","current":24.959325,"twenty":19.081317,"median":20.799559,"eighty":23.806962,"marketCap":171627664948},{"date":"2021-02-26","current":24.004919,"twenty":19.093638,"median":20.862145,"eighty":23.873811,"marketCap":164489659329.96},{"date":"2021-03-05","current":23.404671,"twenty":19.111181,"median":20.875532,"eighty":23.905889,"marketCap":157942482529.58},{"date":"2021-03-12","current":24.089101,"twenty":19.119294,"median":20.889746,"eighty":23.962573,"marketCap":163024135663.81},{"date":"2021-03-19","current":24.138081,"twenty":19.123295,"median":20.904372,"eighty":23.998671,"marketCap":162830497921.9},{"date":"2021-03-26","current":23.193081,"twenty":19.125783,"median":20.915881,"eighty":23.998671,"marketCap":155028423557.96},{"date":"2021-04-01","current":23.52667,"twenty":19.127286,"median":20.926203,"eighty":23.993088,"marketCap":156817423018.8},{"date":"2021-04-09","current":23.983791,"twenty":19.130007,"median":20.934547,"eighty":23.982077,"marketCap":161500891836.66},{"date":"2021-04-16","current":24.585509,"twenty":19.135369,"median":20.954088,"eighty":24.003818,"marketCap":166924602982.29},{"date":"2021-04-23","current":24.888444,"twenty":19.154229,"median":20.969625,"eighty":24.029256,"marketCap":170123633615.16},{"date":"2021-04-30","current":24.781152,"twenty":19.168299,"median":20.983334,"eighty":24.05937,"marketCap":168940260884.15},{"date":"2021-05-07","current":24.862287,"twenty":19.168313,"median":21.002289,"eighty":24.103706,"marketCap":174111030297.4},{"date":"2021-05-14","current":25.680125,"twenty":19.169922,"median":21.008477,"eighty":24.13588,"marketCap":179619740292.48},{"date":"2021-05-21","current":26.638996,"twenty":19.176658,"median":21.021183,"eighty":24.190726,"marketCap":187115548928.29},{"date":"2021-05-28","current":25.873568,"twenty":19.178877,"median":21.040438,"eighty":24.263308,"marketCap":181800162428.55},{"date":"2021-06-04","current":26.345582,"twenty":19.179319,"median":21.053853,"eighty":24.285624,"marketCap":184775704703.34},{"date":"2021-06-11","current":27.692274,"twenty":19.199433,"median":21.083723,"eighty":24.344734,"marketCap":193163556543.63},{"date":"2021-06-18","current":27.562609,"twenty":19.208025,"median":21.096166,"eighty":24.361441,"marketCap":188360125172.74},{"date":"2021-06-25","current":27.369088,"twenty":19.210647,"median":21.103168,"eighty":24.421966,"marketCap":188446101585.45},{"date":"2021-07-02","current":28.401996,"twenty":19.210647,"median":21.114662,"eighty":24.435013,"marketCap":193982287498.47},{"date":"2021-07-09","current":29.15552,"twenty":19.214303,"median":21.129655,"eighty":24.468615,"marketCap":199245918791.31},{"date":"2021-07-16","current":29.748027,"twenty":19.217292,"median":21.161518,"eighty":24.490561,"marketCap":202423046447.21},{"date":"2021-07-23","current":30.548898,"twenty":19.221453,"median":21.201939,"eighty":24.511382,"marketCap":207131156155.73},{"date":"2021-07-30","current":31.028871,"twenty":19.231278,"median":21.213607,"eighty":24.569151,"marketCap":212047874609.99},{"date":"2021-08-06","current":32.395633,"twenty":19.235828,"median":21.24031,"eighty":24.602335,"marketCap":227314943084.39},{"date":"2021-08-13","current":33.444654,"twenty":19.245768,"median":21.264014,"eighty":24.618734,"marketCap":235357755572.42},{"date":"2021-08-20","current":35.162284,"twenty":19.252624,"median":21.284091,"eighty":24.637948,"marketCap":245024372447.53},{"date":"2021-08-27","current":33.317228,"twenty":19.254232,"median":21.299761,"eighty":24.664571,"marketCap":234227686615.91},{"date":"2021-09-03","current":32.51607,"twenty":19.257876,"median":21.307766,"eighty":24.680091,"marketCap":230459438672.73},{"date":"2021-09-10","current":32.4019,"twenty":19.265781,"median":21.308587,"eighty":24.70983,"marketCap":228661682182.4},{"date":"2021-09-17","current":33.217031,"twenty":19.275643,"median":21.31816,"eighty":24.748523,"marketCap":232556230491.03},{"date":"2021-09-24","current":33.133852,"twenty":19.28101,"median":21.366025,"eighty":24.781525,"marketCap":231485444596.91},{"date":"2021-10-01","current":31.636526,"twenty":19.282323,"median":21.379396,"eighty":24.807401,"marketCap":218723923570.81},{"date":"2021-10-08","current":32.62123,"twenty":19.292246,"median":21.424335,"eighty":24.819271,"marketCap":225023326184.09},{"date":"2021-10-15","current":33.946197,"twenty":19.300615,"median":21.441679,"eighty":24.850379,"marketCap":234792449901.15},{"date":"2021-10-22","current":34.940645,"twenty":19.305339,"median":21.46446,"eighty":24.869112,"marketCap":242391720236.88},{"date":"2021-10-29","current":36.321794,"twenty":19.317085,"median":21.481952,"eighty":24.910826,"marketCap":250286576656.34},{"date":"2021-11-05","current":35.845468,"twenty":19.323924,"median":21.485165,"eighty":24.933393,"marketCap":257225403187.95},{"date":"2021-11-12","current":36.23085,"twenty":19.331676,"median":21.507417,"eighty":24.958198,"marketCap":257608851210.18},{"date":"2021-11-19","current":37.116824,"twenty":19.345306,"median":21.532015,"eighty":24.979469,"marketCap":260887858225.31},{"date":"2021-11-26","current":35.192364,"twenty":19.356984,"median":21.55377,"eighty":25.007968,"marketCap":247253528775.96},{"date":"2021-12-03","current":34.779718,"twenty":19.366605,"median":21.564829,"eighty":25.025535,"marketCap":244009518773.87},{"date":"2021-12-10","current":37.077467,"twenty":19.368252,"median":21.595944,"eighty":25.051001,"marketCap":260567603896.15},{"date":"2021-12-17","current":37.755329,"twenty":19.370111,"median":21.624963,"eighty":25.075501,"marketCap":264426435053.61},{"date":"2021-12-23","current":35.286619,"twenty":19.372748,"median":21.642383,"eighty":25.088396,"marketCap":247857298298.99},{"date":"2021-12-31","current":36.268584,"twenty":19.377097,"median":21.651516,"eighty":25.114085,"marketCap":256200781628.71},{"date":"2022-01-07","current":32.760154,"twenty":19.38262,"median":21.653879,"eighty":25.128044,"marketCap":230720648818.99},{"date":"2022-01-14","current":30.818322,"twenty":19.384382,"median":21.68023,"eighty":25.174523,"marketCap":218443964635.68},{"date":"2022-01-21","current":31.136402,"twenty":19.385972,"median":21.684325,"eighty":25.195792,"marketCap":219146324970.82},{"date":"2022-01-28","current":31.503876,"twenty":19.386575,"median":21.723243,"eighty":25.219747,"marketCap":218258768785.68},{"date":"2022-02-04","current":30.817262,"twenty":19.390561,"median":21.761359,"eighty":25.239036,"marketCap":226341444546.24},{"date":"2022-02-11","current":31.24152,"twenty":19.399542,"median":21.802534,"eighty":25.330576,"marketCap":228662000445.22},{"date":"2022-02-18","current":31.558527,"twenty":19.430111,"median":21.831822,"eighty":25.373478,"marketCap":229660563546.04},{"date":"2022-02-25","current":32.080292,"twenty":19.441626,"median":21.877895,"eighty":25.39352,"marketCap":231766624360.89},{"date":"2022-03-04","current":33.411951,"twenty":19.4781,"median":21.910488,"eighty":25.42464,"marketCap":234164709693.38},{"date":"2022-03-11","current":33.00382,"twenty":19.489325,"median":21.991057,"eighty":25.570139,"marketCap":231731491493.28},{"date":"2022-03-18","current":35.330464,"twenty":19.508557,"median":22.016415,"eighty":25.682152,"marketCap":250798493290.2},{"date":"2022-03-25","current":34.179645,"twenty":19.556544,"median":22.061992,"eighty":25.744888,"marketCap":241158119197.15},{"date":"2022-04-01","current":36.167601,"twenty":19.58088,"median":22.185048,"eighty":25.853221,"marketCap":256312426005.84},{"date":"2022-04-08","current":39.273848,"twenty":19.604392,"median":22.28303,"eighty":25.888765,"marketCap":274208694671.97},{"date":"2022-04-14","current":38.556312,"twenty":19.612493,"median":22.335412,"eighty":25.976371,"marketCap":267248834742.15},{"date":"2022-04-22","current":36.480935,"twenty":19.640088,"median":22.368847,"eighty":26.056619,"marketCap":252572523875.96},{"date":"2022-04-29","current":37.41207,"twenty":19.651796,"median":22.515602,"eighty":26.132235,"marketCap":261449903437.4},{"date":"2022-05-06","current":35.97608,"twenty":19.656997,"median":22.648689,"eighty":26.232232,"marketCap":252755242643.39},{"date":"2022-05-13","current":34.493385,"twenty":19.656997,"median":22.845358,"eighty":26.458476,"marketCap":238221359264.86},{"date":"2022-05-20","current":35.04583,"twenty":19.675165,"median":22.946872,"eighty":26.638996,"marketCap":245099073476.37},{"date":"2022-05-27","current":33.993818,"twenty":19.675165,"median":23.004991,"eighty":26.765296,"marketCap":241552454561.86},{"date":"2022-06-03","current":35.85784,"twenty":19.675165,"median":23.079148,"eighty":26.865014,"marketCap":254931773794.05},{"date":"2022-06-10","current":36.144957,"twenty":19.675165,"median":23.121608,"eighty":27.393726,"marketCap":252265073724.1},{"date":"2022-06-17","current":34.368146,"twenty":19.675165,"median":23.166298,"eighty":27.628683,"marketCap":238530918503.83},{"date":"2022-06-24","current":36.164256,"twenty":19.673173,"median":23.179391,"eighty":27.79533,"marketCap":253052972326.23},{"date":"2022-07-01","current":36.078675,"twenty":19.673173,"median":23.204984,"eighty":28.353802,"marketCap":248941614294.24},{"date":"2022-07-08","current":36.733396,"twenty":19.677854,"median":23.233813,"eighty":29.078428,"marketCap":248050939972.16},{"date":"2022-07-15","current":38.477295,"twenty":19.68318,"median":23.265584,"eighty":29.51183,"marketCap":257552595269.26},{"date":"2022-07-22","current":38.62089,"twenty":19.688375,"median":23.297122,"eighty":30.000399,"marketCap":261612605308.42},{"date":"2022-07-29","current":39.238181,"twenty":19.724662,"median":23.3378,"eighty":30.567554,"marketCap":265299833717.82},{"date":"2022-08-05","current":33.9049,"twenty":19.749443,"median":23.369705,"eighty":30.817686,"marketCap":233797066454.36},{"date":"2022-08-12","current":34.532769,"twenty":19.76637,"median":23.399499,"eighty":31.100772,"marketCap":240550497137.24},{"date":"2022-08-19","current":34.567929,"twenty":19.774689,"median":23.44166,"eighty":31.266201,"marketCap":235995645479.41},{"date":"2022-08-26","current":36.735139,"twenty":19.801298,"median":23.478521,"eighty":31.564711,"marketCap":249661078726.81},{"date":"2022-09-02","current":34.711366,"twenty":19.80991,"median":23.496505,"eighty":31.772799,"marketCap":236540335421.77},{"date":"2022-09-09","current":35.772175,"twenty":19.80991,"median":23.516766,"eighty":32.060199,"marketCap":243994236107.81},{"date":"2022-09-16","current":33.577882,"twenty":19.80991,"median":23.52667,"eighty":32.184846,"marketCap":228652198598.3},{"date":"2022-09-23","current":33.562399,"twenty":19.80991,"median":23.562594,"eighty":32.388066,"marketCap":221838450740.96},{"date":"2022-09-30","current":34.097523,"twenty":19.80991,"median":23.603003,"eighty":32.480977,"marketCap":227057441206.74},{"date":"2022-10-07","current":35.608351,"twenty":19.80991,"median":23.647275,"eighty":32.601214,"marketCap":236776826288.97},{"date":"2022-10-14","current":35.762264,"twenty":19.80991,"median":23.66534,"eighty":32.712656,"marketCap":236866879936.7},{"date":"2022-10-21","current":34.927501,"twenty":19.80991,"median":23.70818,"eighty":32.795741,"marketCap":232640407500.32},{"date":"2022-10-28","current":36.334718,"twenty":19.80991,"median":23.736593,"eighty":32.904554,"marketCap":245311415338.91},{"date":"2022-11-04","current":36.025251,"twenty":19.80991,"median":23.752597,"eighty":33.022881,"marketCap":253486391575.29},{"date":"2022-11-11","current":34.287547,"twenty":19.80991,"median":23.772832,"eighty":33.149296,"marketCap":251313592432.59},{"date":"2022-11-18","current":34.747541,"twenty":19.80991,"median":23.820548,"eighty":33.219794,"marketCap":255649995451.18},{"date":"2022-11-25","current":36.32397,"twenty":19.80991,"median":23.872699,"eighty":33.272915,"marketCap":268221502043.66},{"date":"2022-12-02","current":38.36767,"twenty":19.80991,"median":23.960717,"eighty":33.370587,"marketCap":285886880740.46},{"date":"2022-12-09","current":39.419984,"twenty":19.80991,"median":23.997555,"eighty":33.428897,"marketCap":295188583270.58},{"date":"2022-12-16","current":39.679987,"twenty":19.80991,"median":24.019093,"eighty":33.520896,"marketCap":298703535801.33},{"date":"2022-12-23","current":39.96019,"twenty":19.80991,"median":24.061387,"eighty":33.69655,"marketCap":301485653627.93},{"date":"2022-12-30","current":40.109853,"twenty":19.80991,"median":24.103923,"eighty":33.876977,"marketCap":304426156948.21},{"date":"2023-01-06","current":41.371304,"twenty":19.80991,"median":24.138081,"eighty":33.954949,"marketCap":311595753570.44},{"date":"2023-01-13","current":40.043335,"twenty":19.80991,"median":24.196932,"eighty":34.060145,"marketCap":307649341623.7},{"date":"2023-01-20","current":41.293188,"twenty":19.80991,"median":24.278979,"eighty":34.192763,"marketCap":317826418817.7},{"date":"2023-01-27","current":40.512746,"twenty":19.80991,"median":24.336408,"eighty":34.319787,"marketCap":312363369982.79},{"date":"2023-02-03","current":38.279951,"twenty":19.821263,"median":24.361441,"eighty":34.391915,"marketCap":309610899377.72},{"date":"2023-02-10","current":39.341875,"twenty":19.871095,"median":24.42603,"eighty":34.479595,"marketCap":313149317103.2},{"date":"2023-02-17","current":40.045228,"twenty":19.90977,"median":24.463976,"eighty":34.562541,"marketCap":318372635217.12},{"date":"2023-02-24","current":40.496042,"twenty":19.915007,"median":24.48432,"eighty":34.611678,"marketCap":318766342525.9},{"date":"2023-03-03","current":40.975861,"twenty":19.935844,"median":24.507147,"eighty":34.657591,"marketCap":324158568089.14},{"date":"2023-03-10","current":40.578164,"twenty":19.975057,"median":24.580111,"eighty":34.74851,"marketCap":322856968454.74},{"date":"2023-03-17","current":39.61958,"twenty":20.021238,"median":24.6123,"eighty":34.787619,"marketCap":315310491042.1},{"date":"2023-03-24","current":42.504639,"twenty":20.059949,"median":24.63696,"eighty":34.923103,"marketCap":340729066306.94},{"date":"2023-03-31","current":43.986878,"twenty":20.081205,"median":24.660274,"eighty":34.963352,"marketCap":356186060434.07},{"date":"2023-04-06","current":43.573665,"twenty":20.090418,"median":24.675257,"eighty":35.016273,"marketCap":354649239775.55},{"date":"2023-04-14","current":46.360726,"twenty":20.123954,"median":24.72225,"eighty":35.099792,"marketCap":381917782335.83},{"date":"2023-04-21","current":47.142452,"twenty":20.161518,"median":24.781152,"eighty":35.172139,"marketCap":385264690137.54},{"date":"2023-04-28","current":45.530972,"twenty":20.233125,"median":24.806082,"eighty":35.289466,"marketCap":373933894377.33},{"date":"2023-05-05","current":40.221678,"twenty":20.24621,"median":24.819392,"eighty":35.338524,"marketCap":363047622632.38},{"date":"2023-05-12","current":43.154329,"twenty":20.290681,"median":24.861075,"eighty":35.432998,"marketCap":386628394927.04},{"date":"2023-05-19","current":42.211241,"twenty":20.345505,"median":24.894776,"eighty":35.521575,"marketCap":373244274140.24},{"date":"2023-05-26","current":41.751553,"twenty":20.449184,"median":24.92822,"eighty":35.566491,"marketCap":367318344188.2},{"date":"2023-06-02","current":39.666966,"twenty":20.510391,"median":24.955636,"eighty":35.60151,"marketCap":349600627387.28},{"date":"2023-06-09","current":40.04981,"twenty":20.653792,"median":24.980077,"eighty":35.676661,"marketCap":354153777672.53},{"date":"2023-06-16","current":40.491233,"twenty":20.716308,"median":25.014362,"eighty":35.77087,"marketCap":362986228002.22},{"date":"2023-06-23","current":39.918598,"twenty":20.810223,"median":25.038741,"eighty":35.829434,"marketCap":358802036949.56},{"date":"2023-06-30","current":40.314089,"twenty":20.932953,"median":25.075344,"eighty":35.861925,"marketCap":360286538725},{"date":"2023-07-07","current":39.374954,"twenty":20.976299,"median":25.089284,"eighty":35.966485,"marketCap":350956082019.52},{"date":"2023-07-14","current":38.978805,"twenty":21.065152,"median":25.121898,"eighty":36.060509,"marketCap":357860491909.47},{"date":"2023-07-21","current":40.649606,"twenty":21.13475,"median":25.170404,"eighty":36.123479,"marketCap":371604321114.06},{"date":"2023-07-28","current":38.721765,"twenty":21.302742,"median":25.195792,"eighty":36.166932,"marketCap":349150330619.47},{"date":"2023-08-04","current":38.890059,"twenty":21.362374,"median":25.225531,"eighty":36.257943,"marketCap":349308076773.38},{"date":"2023-08-11","current":41.325852,"twenty":21.395991,"median":25.29959,"eighty":36.323535,"marketCap":410900879575.69},{"date":"2023-08-18","current":41.658803,"twenty":21.502217,"median":25.360565,"eighty":36.436734,"marketCap":408744326644.66},{"date":"2023-08-25","current":42.541543,"twenty":21.588834,"median":25.387131,"eighty":36.523925,"marketCap":415627881028.56},{"date":"2023-09-01","current":43.306404,"twenty":21.733119,"median":25.421229,"eighty":36.632702,"marketCap":423860503824.22},{"date":"2023-09-08","current":45.095965,"twenty":21.821469,"median":25.534657,"eighty":36.664011,"marketCap":434973298490.9},{"date":"2023-09-15","current":44.347121,"twenty":21.923559,"median":25.680125,"eighty":36.722709,"marketCap":426429019770.99},{"date":"2023-09-22","current":42.672914,"twenty":22.007754,"median":25.697302,"eighty":36.8332,"marketCap":410366712216.68},{"date":"2023-09-29","current":42.832313,"twenty":22.07509,"median":25.809613,"eighty":37.024096,"marketCap":408154856750.49},{"date":"2023-10-06","current":42.918253,"twenty":22.207177,"median":25.872228,"eighty":37.120894,"marketCap":407370553136.68},{"date":"2023-10-13","current":47.645701,"twenty":22.332343,"median":25.955394,"eighty":37.222236,"marketCap":453163623886.91},{"date":"2023-10-20","current":45.058177,"twenty":22.368839,"median":26.042141,"eighty":37.387666,"marketCap":429143426791.84},{"date":"2023-10-27","current":43.887685,"twenty":22.474887,"median":26.096293,"eighty":37.542146,"marketCap":416210847321.68},{"date":"2023-11-03","current":40.58112,"twenty":22.619194,"median":26.158954,"eighty":37.77108,"marketCap":434666614136.34},{"date":"2023-11-10","current":40.973865,"twenty":22.789886,"median":26.322084,"eighty":37.960754,"marketCap":443200545470.87},{"date":"2023-11-17","current":41.130991,"twenty":22.928807,"median":26.534941,"eighty":38.278815,"marketCap":450826686765.22},{"date":"2023-11-24","current":42.452712,"twenty":22.992251,"median":26.649888,"eighty":38.371172,"marketCap":467665323578.55},{"date":"2023-12-01","current":41.381405,"twenty":23.062639,"median":26.789389,"eighty":38.545427,"marketCap":456059104784.02},{"date":"2023-12-08","current":39.593749,"twenty":23.112425,"median":26.954141,"eighty":38.57852,"marketCap":431591715157.97},{"date":"2023-12-15","current":39.304562,"twenty":23.134475,"median":27.508344,"eighty":38.851988,"marketCap":436596264513.95},{"date":"2023-12-22","current":41.148236,"twenty":23.177477,"median":27.659038,"eighty":38.922456,"marketCap":456927579305.71},{"date":"2023-12-29","current":41.325829,"twenty":23.199394,"median":27.819753,"eighty":38.987376,"marketCap":462412313703.01},{"date":"2024-01-05","current":42.965602,"twenty":23.219176,"median":28.321673,"eighty":39.028723,"marketCap":475548268138.75},{"date":"2024-01-12","current":42.949427,"twenty":23.255339,"median":29.15552,"eighty":39.136713,"marketCap":474914873998.96},{"date":"2024-01-19","current":43.346823,"twenty":23.274802,"median":29.525036,"eighty":39.268766,"marketCap":475852126466.39},{"date":"2024-01-26","current":43.317901,"twenty":23.314329,"median":29.992393,"eighty":39.320568,"marketCap":474294338935.27},{"date":"2024-02-02","current":46.234514,"twenty":23.344449,"median":30.548898,"eighty":39.40203,"marketCap":506862514244.21},{"date":"2024-02-09","current":44.298697,"twenty":23.374655,"median":30.817262,"eighty":39.488965,"marketCap":535221795370.47},{"date":"2024-02-16","current":45.383234,"twenty":23.411773,"median":31.077019,"eighty":39.6254,"marketCap":547956628885.78},{"date":"2024-02-23","current":45.27971,"twenty":23.444798,"median":31.24152,"eighty":39.678225,"marketCap":549774093139.91},{"date":"2024-03-01","current":45.378862,"twenty":23.478521,"median":31.448374,"eighty":39.787357,"marketCap":550685531322.22},{"date":"2024-03-08","current":48.261708,"twenty":23.494902,"median":31.653026,"eighty":39.882371,"marketCap":592559559553.29},{"date":"2024-03-15","current":48.206144,"twenty":23.517781,"median":31.996876,"eighty":39.941116,"marketCap":589179395091.77},{"date":"2024-03-22","current":47.308173,"twenty":23.52667,"median":32.094328,"eighty":40.022913,"marketCap":576513565520.21},{"date":"2024-03-28","current":46.991466,"twenty":23.56157,"median":32.335943,"eighty":40.047061,"marketCap":569565272185.44},{"date":"2024-04-05","current":46.254387,"twenty":23.610109,"median":32.446311,"eighty":40.097352,"marketCap":563782608647.02},{"date":"2024-04-12","current":46.919131,"twenty":23.647275,"median":32.530991,"eighty":40.167772,"marketCap":563484763501.46},{"date":"2024-04-19","current":46.18118,"twenty":23.67588,"median":32.708949,"eighty":40.221678,"marketCap":552244543801.54},{"date":"2024-04-26","current":47.266607,"twenty":23.70686,"median":32.759891,"eighty":40.307445,"marketCap":568400976035.23},{"date":"2024-05-03","current":42.327576,"twenty":23.72852,"median":32.873681,"eighty":40.375437,"marketCap":542032137686.7},{"date":"2024-05-10","current":44.071325,"twenty":23.747994,"median":32.952292,"eighty":40.458052,"marketCap":568398548090.03},{"date":"2024-05-17","current":45.074307,"twenty":23.771696,"median":33.109472,"eighty":40.512846,"marketCap":586312155065.11},{"date":"2024-05-24","current":46.152423,"twenty":23.817376,"median":33.211469,"eighty":40.59745,"marketCap":597689451146.26},{"date":"2024-05-31","current":46.075871,"twenty":23.869365,"median":33.260802,"eighty":40.750309,"marketCap":598005342433.18},{"date":"2024-06-07","current":48.891027,"twenty":23.94497,"median":33.331764,"eighty":40.86245,"marketCap":636965793222.89},{"date":"2024-06-14","current":49.23712,"twenty":23.992049,"median":33.411951,"eighty":40.958693,"marketCap":634015536806.19},{"date":"2024-06-21","current":49.081079,"twenty":24.018117,"median":33.452653,"eighty":40.987349,"marketCap":629548189798.96},{"date":"2024-06-28","current":49.958416,"twenty":24.050958,"median":33.524546,"eighty":40.997999,"marketCap":639945526325.78},{"date":"2024-07-05","current":48.386587,"twenty":24.100535,"median":33.64639,"eighty":41.093615,"marketCap":626172096388.58},{"date":"2024-07-12","current":48.697528,"twenty":24.133679,"median":33.9049,"eighty":41.147287,"marketCap":633375419836.98},{"date":"2024-07-15","current":48.349795,"twenty":24.142207,"median":33.916253,"eighty":41.148236,"marketCap":631319457681.69},{"date":"2024-08-02","current":43.277225,"twenty":24.324844,"median":34.066375,"eighty":41.20492,"marketCap":558433557791.31},{"date":"2024-08-09","current":45.308394,"twenty":24.354431,"median":34.20007,"eighty":41.293188,"marketCap":595404735213.97},{"date":"2024-08-16","current":45.327027,"twenty":24.378479,"median":34.369684,"eighty":41.371304,"marketCap":599974249962.6},{"date":"2024-08-23","current":44.979837,"twenty":24.435013,"median":34.405605,"eighty":41.504975,"marketCap":602123632142.67},{"date":"2024-08-30","current":46.26495,"twenty":24.468615,"median":34.493385,"eighty":41.651415,"marketCap":617587789526.57},{"date":"2024-09-06","current":43.473567,"twenty":24.503203,"median":34.563439,"eighty":41.809219,"marketCap":580445608156.15},{"date":"2024-09-13","current":45.294072,"twenty":24.553916,"median":34.628664,"eighty":41.991754,"marketCap":602074290582.18},{"date":"2024-09-20","current":41.914122,"twenty":24.601207,"median":34.6594,"eighty":42.133495,"marketCap":562891500149.39},{"date":"2024-09-27","current":39.27396,"twenty":24.620356,"median":34.750892,"eighty":42.133495,"marketCap":529136949972.05},{"date":"2024-10-04","current":38.369837,"twenty":24.655215,"median":34.800683,"eighty":42.133495,"marketCap":509214271221.05},{"date":"2024-10-11","current":40.453418,"twenty":24.672651,"median":34.934073,"eighty":42.133495,"marketCap":532616097425.88},{"date":"2024-10-18","current":39.795556,"twenty":24.712429,"median":34.993514,"eighty":42.133495,"marketCap":519765515915.47},{"date":"2024-10-25","current":38.664562,"twenty":24.763881,"median":35.053901,"eighty":42.133495,"marketCap":503297302214.39},{"date":"2024-10-31","current":37.617459,"twenty":24.792436,"median":35.126549,"eighty":42.133495,"marketCap":492283882920.54},{"date":"2024-11-08","current":34.887986,"twenty":24.818477,"median":35.164897,"eighty":42.137734,"marketCap":477919893645.19},{"date":"2024-11-15","current":33.262315,"twenty":24.856702,"median":35.192364,"eighty":42.137734,"marketCap":446793417547.9},{"date":"2024-11-22","current":35.223595,"twenty":24.88501,"median":35.223595,"eighty":42.137734,"marketCap":469179356606.58},{"date":"2024-11-29","current":35.372703,"twenty":24.919825,"median":35.281864,"eighty":42.137734,"marketCap":473954081305.87},{"date":"2024-12-06","current":36.689896,"twenty":24.953215,"median":35.332303,"eighty":42.137734,"marketCap":492636422090.58},{"date":"2024-12-13","current":35.218563,"twenty":24.976183,"median":35.367525,"eighty":42.137734,"marketCap":469483368412.58},{"date":"2024-12-20","current":27.520925,"twenty":25.013317,"median":35.430794,"eighty":42.137734,"marketCap":362794059840.34},{"date":"2024-12-27","current":29.702234,"twenty":25.030076,"median":35.430794,"eighty":42.137734,"marketCap":392886562515.1},{"date":"2025-01-03","current":29.891519,"twenty":25.058285,"median":35.430794,"eighty":42.137734,"marketCap":389201398303.45},{"date":"2025-01-10","current":29.647698,"twenty":25.082233,"median":35.432631,"eighty":42.141973,"marketCap":387516656006.71},{"date":"2025-01-17","current":26.984988,"twenty":25.10605,"median":35.432631,"eighty":42.141973,"marketCap":352861160824.4},{"date":"2025-01-24","current":29.17577,"twenty":25.124624,"median":35.432631,"eighty":42.141973,"marketCap":385565237898.86},{"date":"2025-01-31","current":28.464542,"twenty":25.161796,"median":35.432631,"eighty":42.141973,"marketCap":376696466562.58},{"date":"2025-02-07","current":27.64408,"twenty":25.17357,"median":35.432631,"eighty":42.141973,"marketCap":388211259356.66},{"date":"2025-02-14","current":24.505604,"twenty":25.161796,"median":35.432631,"eighty":42.141973,"marketCap":346492190720.85},{"date":"2025-02-21","current":27.692432,"twenty":25.161796,"median":35.432631,"eighty":42.141973,"marketCap":392454499955.8},{"date":"2025-02-28","current":28.329797,"twenty":25.170588,"median":35.432631,"eighty":42.141973,"marketCap":399184817306.47},{"date":"2025-03-07","current":26.26825,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":385230479837.53},{"date":"2025-03-14","current":23.305599,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":342708135805.47},{"date":"2025-03-21","current":23.24406,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":341394090983.94},{"date":"2025-03-28","current":20.837456,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":304502715067.03},{"date":"2025-04-04","current":18.989096,"twenty":25.192741,"median":35.434467,"eighty":42.146211,"marketCap":284263623540.71},{"date":"2025-04-11","current":18.474808,"twenty":25.184615,"median":35.432631,"eighty":42.141973,"marketCap":279691712454.2},{"date":"2025-04-17","current":18.516566,"twenty":25.17357,"median":35.432631,"eighty":42.141973,"marketCap":284856366575.72}],"updateTime":1745308247146}}}